explore -WSS

explore

author：comprehensive 2025-10-02 19:55:32 - browse：936

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Hospitals are dialing back on venture capital investing

WSS

Be careful with at

Timeline: How the deadly wildfires took over Maui day by day

Videos point to link between seizures and unexplained toddler deaths

Hospitals are dialing back on venture capital investing

Chronically ill young patients struggle to find fertility info

After Optum profits sink, UnitedHealth makes changes

focus

explore

explore

New air purifier tech could be key to improving indoor air quality

Feng Zhang CRISPR delivery startup lays off quarter of staff

Novavax promises a turnaround & Lilly roils the obesity market

Patients, digital health players weigh in on FTC's data privacy plan

State Dept. review finds Biden bears some blame for Afghanistan failures

Biden administration begins canceling student loan debt for 804,000 borrowers

Affirmative action in medical school literally saved lives

Megan Rapinoe shares emotional post following US Women's World Cup exit

BioMarin wins approval for gene therapy to treat hemophilia A

Ahead of JPM, here's who's profiting most in health care

focus

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

BMS, looking to build heart drug business, turns to AI for diagnosis

Morgan Health, with ambitious aims, wants you to know it’s still here

Federal weight loss drug coverage is 30 years out of date

Patients, digital health players weigh in on FTC's data privacy plan

Ahead of JPM, here's who's profiting most in health care

leisure time

focus

hotspot

hotspot